Brugger Stephen B 4
4 · MOMENTA PHARMACEUTICALS INC · Filed Aug 5, 2010
Insider Transaction Report
Form 4
Brugger Stephen B
Chief Operating Officer
Transactions
- Sale
Common Stock
2010-08-03$21.92/sh−18,300$401,136→ 236,775 total - Sale
Common Stock
2010-08-05$18.16/sh−13,896$252,351→ 209,779 total - Sale
Common Stock
2010-08-04$20.85/sh−13,100$273,135→ 223,675 total
Footnotes (4)
- [F1]This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 27, 2008.
- [F2]This transaction was executed in multiple trades at prices ranging from $21.12 to $22.25. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- [F3]This transaction was executed in multiple trades at prices ranging from $20.26 to $21.46. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- [F4]This transaction was executed in multiple trades at prices ranging from $17.20 to $19.25. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.